Market Insights Health Pharmacies OTC Products

Skin Treatment (Pharmacies) - Netherlands

Netherlands

Revenue in the Skin Treatment market is projected to reach €70.08m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.44%, resulting in a market volume of €83.00m by 2029.
In global comparison, most revenue will be generated in the United States (€3,077.00m in 2024).
In relation to total population figures, per person revenues of €3.97 are generated in 2024.

Key regions: Germany, Europe, South Korea, France, China

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Skin Treatment (Pharmacies) market in Netherlands has been experiencing steady growth in recent years. Customer preferences for skincare products have shifted towards natural and organic ingredients, driving the demand for skin treatment products in pharmacies. Additionally, the local special circumstances and underlying macroeconomic factors have also contributed to the development of the market.

Customer preferences: Customers in Netherlands have become increasingly conscious about the ingredients used in skincare products. They are seeking out products that are free from harsh chemicals and artificial additives. This preference for natural and organic ingredients has led to a surge in demand for skin treatment products in pharmacies that offer such products. Customers are also looking for products that are cruelty-free and environmentally sustainable, further driving the demand for ethical skincare brands.

Trends in the market: One of the major trends in the skin treatment market in Netherlands is the rise of clean beauty. Clean beauty refers to products that are made with non-toxic ingredients and are environmentally friendly. This trend has gained popularity among consumers who are looking for safer and more sustainable skincare options. Pharmacies in Netherlands have responded to this trend by stocking a wide range of clean beauty products, including natural and organic skincare brands. Another trend in the market is the growing popularity of anti-aging products. As the population in Netherlands ages, there is a higher demand for skincare products that target signs of aging, such as wrinkles and fine lines. Pharmacies have capitalized on this trend by offering a variety of anti-aging treatments, including serums, creams, and masks. These products often contain ingredients like retinol and hyaluronic acid, which are known for their anti-aging properties.

Local special circumstances: The Netherlands has a well-developed healthcare system, which includes a strong network of pharmacies. Pharmacies in the country play a crucial role in providing healthcare services and advice to the population. This has created a favorable environment for the growth of the skin treatment market in pharmacies. Customers trust pharmacies as a reliable source of skincare products and often seek professional advice from pharmacists when choosing products.

Underlying macroeconomic factors: The Netherlands has a stable economy and a high standard of living, which has contributed to the growth of the skin treatment market. As consumers have more disposable income, they are willing to spend more on skincare products. The skincare industry in Netherlands has also benefited from the growing trend of self-care and wellness. Consumers are increasingly prioritizing their skincare routines and are willing to invest in high-quality products to maintain healthy and radiant skin. In conclusion, the Skin Treatment (Pharmacies) market in Netherlands is developing due to customer preferences for natural and organic ingredients, the rise of clean beauty, the growing demand for anti-aging products, the presence of a well-developed healthcare system, and the underlying macroeconomic factors such as a stable economy and high disposable income. Pharmacies in Netherlands have capitalized on these trends and special circumstances by offering a wide range of skincare products and professional advice to meet the needs of their customers.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.